Abstract:Mycobacterium tuberculosis ( M . tb ), the causative agent of tuberculosis (TB), is a leading global cause of death from infectious disease. Biofilms are increasingly recognized as a relevant growth form during M . tb infection and may impede treatment by enabling bacterial drug and immune tolerance. M . tb has a complicated regulatory network that has been well-characterized for many relevant disease states, including dormancy and hypoxia. However, despite its importance, our knowledge of the genes and pathways involved in biofilm formation is limited. Here we characterize the biofilm transcriptomes of fully virulent clinical isolates and find that the regulatory systems underlying biofilm growth vary widely between strains and are also distinct from regulatory programs associated with other environmental cues. We used experimental evolution to investigate changes to the transcriptome during adaptation to biofilm growth and found that the application of a uniform selection pressure resulted in loss of strain-to-strain variation in gene expression, resulting in a more uniform biofilm transcriptome. The adaptive trajectories of transcriptomes were shaped by the genetic background of the M . tb population leading to convergence on a sub-lineage specific transcriptome. We identified widespread upregulation of non-coding RNA (ncRNA) as a common feature of the biofilm transcriptome and hypothesize that ncRNA function in genome-wide modulation of gene expression, thereby facilitating rapid regulatory responses to new environments. These results reveal a new facet of the M . tb regulatory system and provide valuable insight into how M . tb adapts to new environments. Understanding mechanisms of resistance and tolerance in Mycobacterium tuberculosis ( M . tb ) can help us develop new treatments that capitalize on M . tb 's vulnerabilities. Here we used transcriptomics to study both the regulation of biofilm formation in clinical isolates as well as how those regulatory systems adapt to new environments. We find that closely related clinical populations have diverse strategies for growth under biofilm conditions, and that genetic background plays a large role in determining the trajectory of evolution. These results have implications for future treatment strategies that may be informed by our knowledge of the evolutionary constraints on strain(s) from an individual infection. This work provides new information about the mechanisms of biofilm formation in M . tb and outlines a framework for population level approaches for studying bacterial adaptation.

Thiol reductive stress induces cellulose-anchored biofilm formation in Mycobacterium tuberculosis

Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis

Adaptation of the Mycobacterium tuberculosis transcriptome to biofilm growth

Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistance

Mycobacterial biofilms: Understanding the genetic factors playing significant role in pathogenesis, resistance and diagnosis

Mycobacterial Biofilm: Mechanisms, Clinical Problems, and Treatments

Cellulase Promotes Mycobacterial Biofilm Dispersal in Response to a Decrease in the Bacterial Metabolite Gamma-Aminobutyric Acid

Divergent downstream biosynthetic pathways are supported by L-cysteine synthases of Mycobacterium tuberculosis

Mycobacterium tuberculosis survival and biofilm formation studies: effect of d-amino acids, d-cycloserine and its components

Proteomic characterization of Mycobacterium tuberculosis subjected to carbon starvation

Mycobacterium Tuberculosis Biofilm Matrix and Potential Drug Targets and Treatment Strategies

Mycobacterium Biofilms: Factors Involved in Development, Dispersal, and Therapeutic Strategies Against Biofilm-Relevant Pathogens.

Gene expression profile analysis and target gene discovery of Mycobacterium tuberculosis biofilm

Mycobacterium tuberculosis Rv2617c is involved in stress response and phage infection resistance

Three-dimensional low shear culture of Mycobacterium bovis BCG induces biofilm formation and antimicrobial drug tolerance

The sensor kinase MtrB of Mycobacterium tuberculosis regulates hypoxic survival and establishment of infection

MtrA regulation of essential peptidoglycan cleavage in Mycobacterium tuberculosis during infection

Contingencies in biofilm adaptation of Mycobacterium tuberculosis

Effects of CwlM on Autolysis and Biofilm Formation in Mycobacterium Tuberculosis and Mycobacterium Smegmatis.

TcrXY is an acid-sensing two-component transcriptional regulator of Mycobacterium tuberculosis required for persistent infection

Epinephrine Stimulates Mycobacterium tuberculosis Growth and Biofilm Formation